Media and News
PharmaNova to Present at BioTech Showcase 2013 held at the Parc 55 Wyndham, Union Square in San Francisco, CA held on January 7-9 2013.
PharmaNova Inc.will be presenting at the BioTech Showcase 2013 held at the Parc 55 Wyndham, Union Square in San Francisco, CA held on January 7-9 2013. The presentation will held on Wednesday January 9, 2013 at 11:45 am PST (Private Biotech Track B, Mission 1) and will showcase PharmaNova's proprietary NovaSperse℠ nanoparticle technology. Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives.
Conference details can be found at:
PharmaNova Inc. is a privately held pharmaceutical company. Our product candidates are derived from the re‐positioning and enhancement of known drugs using our proprietary NovaSperse℠ nanoparticle technology platform. We address low risk, fast to market products in areas of clear medical need and generate revenue from partnering and licensing strategies with commercialization partners and clients worldwide. PharmaNova also conducts contractual formulation development work applying NovaSperse℠ technology to client‐owned products and compounds to support new product development or the extended life cycle management of existing products. PharmaNova has other new product candidates in various stages in its development pipeline. Our focus is on the development of novel, improved nanoparticle formulations of ophthalmic and anti-infective products.
« Back to Media
Member of the media wishing to learn more about Pharmanova should contact:
Rafael Larramendi, President | Rafael.email@example.com | (585) 413-4721.